chrX-151397323-T-G
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001017980.4(VMA21):āc.15T>Gā(p.Asp5Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000434 in 1,161,102 control chromosomes in the GnomAD database, including 1 homozygotes. There are 182 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001017980.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VMA21 | NM_001017980.4 | c.15T>G | p.Asp5Glu | missense_variant | 1/3 | ENST00000330374.7 | |
VMA21 | NM_001363810.1 | c.218+266T>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VMA21 | ENST00000330374.7 | c.15T>G | p.Asp5Glu | missense_variant | 1/3 | 1 | NM_001017980.4 | P1 | |
VMA21 | ENST00000370361.5 | c.218+266T>G | intron_variant | 5 | |||||
VMA21 | ENST00000477649.1 | n.133+676T>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000354 AC: 40AN: 113102Hom.: 0 Cov.: 24 AF XY: 0.000198 AC XY: 7AN XY: 35266
GnomAD3 exomes AF: 0.000426 AC: 43AN: 100939Hom.: 1 AF XY: 0.000618 AC XY: 22AN XY: 35601
GnomAD4 exome AF: 0.000443 AC: 464AN: 1048000Hom.: 1 Cov.: 30 AF XY: 0.000511 AC XY: 175AN XY: 342220
GnomAD4 genome AF: 0.000354 AC: 40AN: 113102Hom.: 0 Cov.: 24 AF XY: 0.000198 AC XY: 7AN XY: 35266
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.15T>G (p.D5E) alteration is located in exon 1 (coding exon 1) of the VMA21 gene. This alteration results from a T to G substitution at nucleotide position 15, causing the aspartic acid (D) at amino acid position 5 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 22, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
VMA21-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 15, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
X-linked myopathy with excessive autophagy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | VMA21: BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at